Who Paid My Doc Search
Menu
Organisation paid for research Program year 2024 Source: CMS Open Payments

PHS Rosedale Infectious Diseas

Neither a doctor nor a teaching hospital

Research payments

$213,157

29 payments

Through program year 2024, PHS Rosedale Infectious Diseas is reported as receiving $213,157 in research payments, across 29 payments.

By program year

4 rows
Year Kind Amount Payments
2024 Research $10,784 4
2023 Research $22,416 2
2022 Research $55,015 12
2021 Research $124,942 11

Breakdown

Who paid Research payments · program years 2021–2024
  1. ViiV Healthcare Company $202,373 25 payments
  2. GlaxoSmithKline, LLC. $10,784 4 payments
Studies the money was for Research payments · program years 2021–2024
  1. A Phase Iiib, Randomized, Multicenter, Active-Controlled, Parallel-Gro $192,531 22 payments
  2. A Phase Iiib, Multi-Center, Non-Randomized, Parallel-Group, Open-Label $10,784 4 payments
  3. A Phase III, Randomized, Multicenter, Parallel-Group, Non-Inferiority $9,842 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record